A Phase II Study of Carboplatin, Nab-paclitaxel and Cetuximab for Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2018
At a glance
- Drugs Carboplatin (Primary) ; Cetuximab (Primary) ; Paclitaxel (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 30 Jun 2017 Planned End Date changed from 1 Feb 2018 to 1 Apr 2020.
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.